TX SB1619

Expands the definition of "epinephrine delivery system" beyond auto-injectors to include any FDA-approved medical delivery device for treating anaphylaxis, specifically adding epinephrine nasal spray as an approved option

Applies to multiple entity types including school districts, charter schools, private schools, institutions of higher education, day-care centers, amusement parks, youth camps, restaurants, sports venues, emergency medical services providers, and law enforcement agencies

Requires the Executive Commissioner of the Health and Human Services Commission to adopt rules on maintenance, administration, and disposal of epinephrine delivery systems, including establishing training requirements for personnel and volunteers

Maintains existing immunity protections for persons who in good faith prescribe, dispense, administer, or take other actions related to epinephrine delivery systems under the amended statutes

Takes effect immediately if passed by two-thirds vote of both legislative chambers, otherwise September 1, 2025; passed Senate 31-0 on April 1, 2025 and House 140-0 on April 30, 2025